E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/27/2013 in the Prospect News Structured Products Daily.

Structured products volume $1.43 billion for week of Feb. 17; BofA Merrill Lynch tops bookrunners

By Sheri Kasprzak

New York, Feb. 27 - Volume for structured products reached $1.43 billion in 168 deals for the week of Feb. 17, a massive 103.82% increase over the previous week, according to Prospect News data. Comparatively, during the week of Feb. 10, there were 158 deals totaling $703 million.

Excluding exchange-traded notes, volume topped $1.16 billion in 155 deals, compared to $541 million in 146 deals in the week of Feb. 10, an increase of 113.48%.

Smaller deals made up the majority of the action, with 31 offerings totaling $10 million or more, compared to 15 deals the week before. There were 17 deals that topped $20 million, compared to just four the week before, and only three deals larger than $50 million, with none of that size the previous week.

Top bookrunner

Moving to the leading bookrunners, BofA Merrill Lynch took the top spot once again. BofA was the bookrunner for $730 million of structured products, excluding ETNs, for a total of 63.22% of all structured products priced during the week of Feb. 17. BofA also took the top spot the week of Feb. 10, with $17 million in deals.

Goldman Sachs & Co. was the number-two bookrunner for the week of Feb. 17, selling $87 million of structured products excluding ETNs, making up 7.51% of the market, up 11.84% from the week of Feb. 10.

UBS AG was the bookrunner for $67 million of structured products excluding ETNs during the week of Feb. 17, down 7.47% from the week of Feb. 10.

Equities top underliers

Equities were the top underlier for the week of Feb. 17, with $1.02 billion in deals linked to equities, comprising 88.61% of the deals with 129 priced. The week of Feb. 10, there were also 129 notes linked to equities, but just $413 million of equity-linked products priced, marking an increase of 147.8% week over week.

Synthetics were the second-largest underlier, with $137 million of bonds linked to synthetics, making up just 11.89% of offerings during the week of Feb. 17, down 7.54% from the week of Feb. 10 when $148 million of offerings were linked to synthetics.

Synthetic ETFs rounded out the top three underliers, with $55 million of deals linked to synthetic ETFs, an increase of 242.83% from the week of Feb. 10 when $16 million of deals were linked to synthetic ETFs.

Reverse convertibles lead

Heading up the structures, leveraged return notes took the lead with $469 million of leveraged return notes priced during the week of Feb. 17, making up 40.63% of offerings, up sharply from the week of Feb. 10 when just $35 million of leveraged return notes were priced.

$2.91 billion priced in month

Looking to month-to-date numbers, $2.91 billion of structured products offerings were priced in 484 deals from Feb. 1 to Feb. 23. This is a 0.46% increase from the previous month, in which $2.9 billion of structured products offerings were priced in 397 deals.

During the same period in February 2012, there were $3.19 billion of structured products offerings priced in 542, a decline of 8.78%.

Excluding ETNs, there were $2.29 billion in offerings priced in 438 deals compared with $1.96 billion priced for the same period in January, an increase of 16.89% month over month.

Year to date, there have been $7.52 billion of new structured products offerings priced in 1,226 deals, up 11.6% for the same period in 2012.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.